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Background: Studies of the prevalence of dyslipidemia and its association with insomnia are scarce in China. This
study investigated the prevalence of dyslipidemia and its association with insomnia in a community based Chinese
population.
Methods: We conducted a cross-sectional survey in Beijing and recruited 10054 participants aged ≥18 years. The
association between self-reported insomnia and dyslipidemia was determined by multiple logistic regression
models. Age, gender, education, obesity, body mass index, physical activity, current smoking, current drinking,
diabetes, and hypertension were adjusted as confounders. Odds ratios (ORs) with corresponding 95% confidence
intervals (CIs) were reported as effect measurements.
Results: The prevalence of dyslipidemia in those with no insomnia, occasional insomnia, and frequent insomnia
were 53.3%, 54.3%, and 54.5% in men and 52.0%, 54.8%, and 61.2% in women. Compared with subjects with no
insomnia, the multivariate adjusted ORs and 95% CIs for those with occasional insomnia and frequent insomnia
were 1.07(0.86 ~ 1.34) and 1.19(0.89 ~ 1.60) for men, and 1.00(0.86 ~ 1.14) and 1.23(1.03 ~ 1.47) for women.
Conclusions: These observations indicate that frequent insomnia was associated with a higher prevalence of
dyslipidemia in women. This association was not significant in men.
Keywords: Insomnia, Dyslipidemia, Total cholesterol, Chinese population, Cross-sectional studyBackground
Dyslipidemia is one of the most import and modifiable
risk factors for atherosclerosis [1], stroke [2], and cardio-
vascular diseases [3]. Previous studies reported that the
prevalence of dyslipidemia in China was lower than that
in Western countries in the year around 2000 [4-9].
Nevertheless, China has been developing so rapidly dur-
ing the last decades. The fast economic growth and so-
cial change are accompanied by transformation of daily
lifestyle of the ordinary people. The prevalence of dyslip-
idemia might also have been changed and different from* Correspondence: jmy@fudan.edu.cn
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unless otherwise stated.those in the previous reports. Thus, an update of our
knowledge regarding the prevalence of dyslipidemia is
largely on the agenda.
Studies suggested that sleep deprivation might be asso-
ciated with dyslipidemia [10-12]. But few of them exam-
ined the association between insomnia and dyslipidemia
in a population based survey. Insomnia is a subjective
feeling of having difficulty initiating, maintaining or re-
storing sleep, or having poor sleep quality [13]. It was re-
ported to be associated with substantial impairments of
an individual’s quality of life [14], depression [15], and
accident occurrence [16]. Although recent studies have
showed that insomnia was associated with higher risks
of cardiovascular diseases [17,18], more research is
needed to clarify its relationship with dyslipidemia. The
primary objective of the present study as a priori was
to test whether insomnia was associated with highertd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Zhan et al. BMC Public Health 2014, 14:1050 Page 2 of 9
http://www.biomedcentral.com/1471-2458/14/1050prevalence of taking into account of several established
risk factors of dyslipidemia based on a community-based
survey in a Chinese population.
Methods
Study design
This survey was a cross-sectional study regarding chronic
diseases and risk factors conducted in Beijing in 2007 [19].
Citizens or permanent residents ≥18 years old were en-
rolled by a multistage stratified random sampling design.
According to local economic development level, two
urban districts, one urban–rural mixed district, and one
rural district were selected, and then 38 communities (17
urban communities and 21 rural communities) were ran-
domly sampled. Before collecting the data, we informed
local administrators of the aim and method of our survey.
With their help, we could convey information of our study
design via broadcasting and booklets. At the night be-
fore our survey, the participants were told not to drink
or eat from 8 pm to 8 am the next day. Written in-
formed consents were obtained from all study partici-
pants, and the ethical approval was obtained from the
Ethic Committee of Beijing Municipal Science and
Technology Commission.
Sample
In total, we intended to recruit around 300 participants
in each study community. Finally, 12041 participants
were invited, and 10054 participants were recruited with
a response rate of 83.5%. Of them, 3687(36.7%) were
men and 6367(63.3%) were women. The age of men in
our sample ranged from 20 to 96 years with a median
age being 53 years. Likewise, the age of women in this
sample ranged from 20 to 91 years with a median age
being 53 years.
Data collection
The health interview was performed by trained medical
staff at community health centers using a well-established
and validated questionnaire to collect demographic and
behavioral characteristics of the study population. Demo-
graphic information included birthday, gender, and educa-
tion. Behavioral information included current smoking
status, current drinking status, and physical activities. Edu-
cation level was categorized as elementary school or lower
(<7 years), middle or high school (7 ~ 12 years), and col-
lege or higher (>12 years).
Physical examination included anthropometric mea-
surements, blood pressure, medical history, and drug ad-
ministration history. Height and weight were measured
to the nearest 0.1 cm and 0.1 kg respectively with the
subject standing barefoot in light clothes. Waist circum-
ference was measured to the nearest 0.1 cm at the mid-
point between the 12th rib and right anterior superioriliac spine. Body mass index (BMI) was calculated as
weight (kg) to be divided by square of height (m). Blood
pressure was measured using standard mercury sphyg-
momanometer on the right arm in sitting position after
the participants rested for 5 minutes. Phase 1 and phase
5 Korotkoff sound was used as systolic blood pressure
(SBP) and diastolic blood pressure (DBP) respectively.
Blood pressure was measured twice with the average re-
sults for the present data analysis. Medical history and
drug administration history were obtained from medical
records and confirmed by community general practi-
tioners. All the measurements were adopted by commu-
nity licensed physicians.
Blood samples were collected from all the participants
after an overnight fasting. All the biochemical assess-
ments were conducted in the central laboratory of Pe-
king University People’s Hospital. Concentrations of
fasting glucose, total cholesterol (TC), high-density lipo-
protein cholesterol (HDL-C), triglycerides (TG), and
low-density lipoprotein cholesterol (LDL-C) were mea-
sured using an auto analyzer (Hitachi 717, Hitachi In-
struments Inc., Tokyo, Japan). Diabetes mellitus was
defined as fasting glucose ≥7.0 mmol/L or current medi-
cation for diabetes [20]. Hypertension was defined as
SBP ≥140 mmHg, DBP ≥90 mmHg, or current medica-
tion for hypertension [21]. Obesity was defined as waist
circumstances >90 cm in men and >85 cm in women.
Determination of self-reported insomnia and dyslipidemia
Self-reported insomnia was collected via a question:
“During the last month, have you had insomnia (e.g.: dif-
ficulty falling asleep or non-restorative sleep)?” with the
following response options: no insomnia, occasional
insomnia (1–2 times/week), and frequent insomnia (≥3
times/week). Abnormal TC was defined as TC > 5.18
mmol/L, abnormal TG was defined as TG > 1.70 mmol/L,
abnormal LDL-C was defined as LDL-C > 3.37 mmol/L,
and abnormal HDL-C was defined as HDL-C < 1.04
mmol/L. Dyslipidemia was defined as any of the followings
being abnormal: TC, TG, LDL-C, or HDL-C according to
Chinese Guidelines on Prevention and Treatment of Dys-
lipidemia in Adults [22].
Statistical analysis
Continuous variables were presented as mean ± standard
deviation (SD) and categorical variables were presented
as frequencies and proportions. In the descriptive ana-
lysis, we present the basic characteristics of study
subjects and the prevalence of dyslipidemia and its indi-
vidual components by insomnia. Cochran-Armitage
method [23], which was developed for linear trends test
in proportions or frequencies, was used for trend test in
the associations between insomnia status (no insomnia,
occasional insomnia, and frequent insomnia) and lipid
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the association between insomnia and dyslipidemia using
multiple logistic regression models in both men and
women altogether. We also examined the interaction
terms and found that there was an interaction effect be-
tween gender and insomnia for dyslipidemia. Then we
examined the association in men and women separately.
Three models were used for the analysis. The first model
only included insomnia followed by the second model
adjusted for age (plus gender for both genders together)








Age(years) 52.4 ± 13.6 52.7 ± 12.9 56.4 ± 1
BMI(kg/m2) 25.1 ± 3.7 24.9 ± 3.7 24.5 ± 3
TC(mmol/L) 4.71 ± 0.91 4.70 ± 0.92 4.73 ± 1
TG(mmol/L) 1.64 ± 1.77 1.62 ± 1.65 1.47 ± 1
LDL-C(mmol/L) 2.44 ± 0.67 2.43 ± 0.64 2.44 ± 0
HDL-C(mmol/L) 1.27 ± 0.40 1.24 ± 0.28 1.26 ± 0
Education, n(%)
0 ~ 6 years 663(21.6) 85(21.3) 62(27.9
7 ~ 12 years 2000(65.3) 256(64.0) 133(59.
>12 years 402(13.1) 59(14.8) 27(12.2
Physical Activity, n(%)
No 1467(47.9) 206(51.5) 104(46.
Yes 1598(52.1) 194(48.5) 118(53.
Current Smoking, n(%)
No 829(27.0) 109(27.3) 49(22.1
Yes 2236(73.0) 291(72.7) 173(77.
Current Drinking, n(%)
No 1504(49.1) 207(51.8) 113(50.
Yes 1561(50.9) 193(48.2) 109(49.
Obesity, n(%)
No 1672(54.6) 221(55.3) 135(60.
Yes 1393(45.4) 179(44.7) 87(39.2
Work stress, n(%)
Low 391(12.8) 47(11.8) 31(14.0
Intermediate 1695(55.3) 190(47.5) 84(37.8
High 978(31.9) 163(40.8) 107(48.
Diabetes, n(%)
No 2719(88.7) 351(87.7) 199(89.
Yes 346(11.3) 49(12.3) 23(10.4
Hypertension, n(%)
No 1824(59.5) 240(60.0) 130(58.
Yes 1240(40.5) 160(40.0) 92(41.4for BMI, education, current smoking, current drinking,
physical activity, obesity, diabetes, and hypertension as
confounders. Odds ratios (ORs) with 95% confidence in-
tervals (CIs) were presented, and P < 0.05 was considered
to be statistically significant. All of the statistical analyses
were conducted using R 2.15 [24].
Results
Basic characteristics of study subjects
Table 1 demonstrates the basic characteristics of study









3.7 51.4 ± 13.2 54.4 ± 12.4 56.5 ± 11.8
.5 25.6 ± 4.1 25.4 ± 4.1 25.2 ± 3.9
.08 4.89 ± 0.98 4.98 ± 1.02 5.08 ± 1.00
.23 1.45 ± 1.24 1.48 ± 1.28 1.49 ± 1.11
.70 2.54 ± 0.70 2.57 ± 0.71 2.62 ± 0.67
.32 1.36 ± 0.29 1.37 ± 0.30 1.38 ± 0.32
) 1398(30.6) 425(37.1) 291(44.4)
9) 2698(59.1) 625(54.6) 312(47.6)
) 471(10.3) 95(8.3) 52(7.9)
8) 2048(44.9) 495(43.3) 274(41.8)
2) 2516(55.1) 649(56.7) 381(58.2)
) 4186(91.7) 1028(89.9) 565(86.3)
9) 381(8.3) 116(10.1) 90(13.7)
9) 4351(95.3) 1088(95.0) 622(95.0)
1) 215(4.7) 57(5.0) 33(5.0)
8) 2365(51.8) 585(51.1) 333(50.8)
) 2202(48.2) 560(48.9) 322(49.2)
) 591(12.9) 119(10.4) 61(9.3)
) 2547(55.8) 574(50.2) 291(44.6)
2) 1428(31.3) 451(39.4) 301(46.1)
6) 4077(89.3) 1004(87.7) 567(86.6)
) 490(10.7) 141(12.3) 88(13.4)
6) 2957(64.7) 641(56.0) 326(49.8)
) 1610(35.3) 504(44.0) 329(50.2)
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and frequent insomnia were 3065(83.1%), 400(10.8%),
and 222(6.1%), respectively, and those of women were
4567(71.7%), 1145(18.0%), and 655(10.3%). The average
ages of the subjects with no insomnia, occasional insom-
nia, and frequent insomnia were 52.4 ± 13.6, 52.7 ± 12.9,
and 56.4 ± 13.7 years for men, while those for women
were 51.4 ± 13.2, 54.4 ± 12.4, and 56.5 ± 11.8 years,
respectively. Of the 10054 participants, 5374(53.5%)
were found with dyslipidemia. The concentrations of
TC, TG, LDL-C, and HDL-C among different insomnia
status were plotted in Figure 1 for men and Figure 2 for
women.
Prevalence of abnormal lipid profile
As shown in Table 2, the prevalence of dyslipidemia for
those with no insomnia, occasional insomnia, and fre-
quent insomnia were 53.3%, 54.3%, and 54.5% in men
and 52.0%, 54.8%, and 61.2% in women. The Cochran-
Armitage trend test for the prevalence of dyslipidemia
across different insomnia status was P <0.0001 for all
participants. These trend tests were not consistent in
men (P = 0.6313) and women (P <0.0001).
Association of insomnia and abnormal lipid profile
Table 3 presents the association of serum lipid markers
(TC, TG, LDL-C, and HDL-C) and insomnia. All ofFigure 1 Concentration of TC, TG, LDL-C, and HDL-C by insomnia in mthese models included age, BMI, education, physical ac-
tivity, current smoking, current drinking, obesity, dia-
betes, and hypertension plus gender when men and
women were analyzed together. ORs (95% CI) of TC for
those with occasional insomnia, frequent insomnia were
1.00(0.79 ~ 1.27) and 1.15(0.85 ~ 1.57) compared with
those with no insomnia in men. As for women, the ORs
(95% CI) of TC were 1.04(0.91 ~ 1.20) and 1.24(1.05 ~
1.49) for the participants with occasional insomnia and
frequent insomnia. In terms of TG, LDL-C, and HDL-C,
their associations with insomnia were not statistically
significant. Additional analysis was made when treating
serum lipids as continuous variables corresponding to
Figures 1 and 2 by gender. We only observed significant
results for TC in women (P <0.001).
Association of insomnia and dyslipidemia
The association of insomnia and dyslipidemia were de-
scribed in Table 4. Model 1 included only insomnia,
model 2 was adjusted for age (plus gender when men
and women were analyzed together), and model 3 was
further adjusted for several other confounders (BMI,
education, physical activity, current smoking, current
drinking, obesity, diabetes, and hypertension). Compared
with those without insomnia, the corresponding ORs
and 95% CI for subjects with occasional insomnia and
frequent insomnia were 1.07(0.86, 1.34) and 1.19(0.89,en.
Figure 2 Concentration of TC, TG, LDL-C, and HDL-C by insomnia in women.
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for women in the multivariable adjusted models. The
ORs were not substantially different in the other models.
Discussion
Previous studies regarding sleep disorder or serum lipid
were well documented in literature. Nevertheless, to ourTable 2 Prevalence of dyslipidemia among subjects with diffe
Abnormal TC Abnormal T
All
No Insomnia 2457(32.2) 2100(27.5)
Occasional Insomnia 558(36.1) 431(27.9)
Frequent Insomnia 361(41.2) 238(27.1)
P* <0.0001 0.9525
Men
No Insomnia 845(27.6) 885(28.9)
Occasional Insomnia 110(27.5) 125(31.3)
Frequent Insomnia 67(30.2) 57(25.7)
P* 0.5001 0.7232
Women
No Insomnia 1612(35.3) 1215(26.6)
Occasional Insomnia 448(39.1) 306(26.7)
Frequent Insomnia 294(44.9) 181(27.6)
P* <0.0001 0.6173
*Cochran-Armitage trend test.knowledge, few researches were conducted to explore
insomnia and dyslipidemia simultaneously or examine
the association between them, especially in the Chinese
population [25]. In the present study, we investigated
the association between self-reported insomnia and
dyslipidemia and serum lipid markers in a community-
based sample and found that frequent insomnia wasrent insomnia status [n(%)]













Table 3 Odds ratios and 95% confidence intervals between insomnia and TC, TG, LDL-C, and HDL-C
TC TG LDL-C HDL-C
All
No Insomnia 1 1 1 1
Occasional Insomnia 1.06(0.94 ~ 1.20) 1.03(0.91 ~ 1.18) 1.05(0.88 ~ 1.26) 0.96(0.81 ~ 1.13)
Frequent Insomnia 1.25(1.07 ~ 1.45) 1.01(0.85 ~ 1.20) 1.07(0.86 ~ 1.34) 1.07(0.87 ~ 1.31)
Men
No Insomnia 1 1 1 1
Occasional Insomnia 1.01(0.79 ~ 1.28) 1.20(0.94 ~ 1.54) 0.87(0.58 ~ 1.31) 1.07(0.83 ~ 1.39)
Frequent Insomnia 1.17(0.86 ~ 1.58) 1.08(0.77 ~ 1.52) 1.19(0.74 ~ 1.92) 1.13(0.80 ~ 1.59)
Women
No Insomnia 1 1 1 1
Occasional Insomnia 1.05(0.91 ~ 1.21) 0.92(0.79 ~ 1.08) 1.08(0.88 ~ 1.32) 0.86(0.69 ~ 1.07)
Frequent Insomnia 1.25(1.05 ~ 1.50) 0.93(0.76 ~ 1.13) 1.03(0.80 ~ 1.33) 1.00(0.77 ~ 1.29)
TC, total cholesterol; TG, triglyceride; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol.
Models for all: insomnia, age, education, obesity, BMI, physical activity, current smoking, current drinking, work stress, hypertension, and diabetes (plus gender
when men and women analyzed together).
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compared with those who reported no insomnia in
women. This association was not statistical significant in
men and independent of age, BMI, education, physical
activity, current smoking, current drinking, obesity, dia-
betes, and hypertension.
Insomnia is usually accompanied with short sleep dur-
ation. Recent study suggested that short sleep duration
was associated with higher risks of hypercholesterolemia
in the adults of US [11] and Japan [12]. Likewise, re-
duced sleep duration was found to be related to dyslipid-
emia in other studies [26,27]. However, some other
studies reported different results which stated difficulty




Occasional Insomnia 1.08(0.98 ~
Frequent Insomnia 1.33(1.15 ~
Men
No Insomnia 1
Occasional Insomnia 1.04(0.84 ~
Frequent Insomnia 1.05(0.80 ~
Women
No Insomnia 1
Occasional Insomnia 1.12(0.98 ~
Frequent Insomnia 1.46(1.23 ~
Model 1: insomnia.
Model 2: insomnia, age (plus gender when men and women analyzed together).
Model 3: insomnia, age, education, obesity, BMI, physical activity, current smoking,
men and women analyzed together).[28]. Different study design, source population, and so-
cioeconomic status might explain the discrepancy. Previ-
ous studies also implied that women were more prone
to suffer from insomnia than men [29,30], and gender
also played a key role in cardiovascular diseases and
mortality [31]. Therefore, a gender inequality of the as-
sociation between self-reported insomnia and dyslipid-
emia would be plausible. In our study, more women had
insomnia than men (P < 0.0001). On the contrary, the
prevalence of dyslipidemia in women was almost identi-
cal to that in men (P = 0.99). Thus, we hypothesized that
the association between insomnia and dyslipidemia
might be affected by gender. Our results did not contra-
dict this hypothesis. The association of self-reportedsomnia and dyslipidemia
1 Model 2 Model 3
1 1
1.21) 1.01(0.91 ~ 1.14) 1.06(0.94 ~ 1.19)
1.53) 1.17(1.01 ~ 1.35) 1.28(1.10 ~ 1.49)
1 1
1.28) 1.04(0.84 ~ 1.28) 1.08(0.87 ~ 1.36)
1.38) 1.05(0.80 ~ 1.39) 1.21(0.90 ~ 1.63)
1 1
1.27) 0.96(0.84 ~ 1.10) 1.00(0.87 ~ 1.15)
1.72) 1.15(0.97 ~ 1.38) 1.25(1.04 ~ 1.50)
current drinking, work stress, hypertension, and diabetes (plus gender when
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tween men and women. Insomnia might pose more risk
to dyslipidemia in women. The reasons of the observed
gender difference in the association between insomnia
and dyslipidemia remains unclear, but recent research
results were still able to provide suggestive clues. Firstly,
it was reported that women were more prone to suffer
psychiatric disorders and lacking coping ability [32,33],
both of which were related to sleep disorders. In
addition to that, sex hormone was also found to be of
paramount significance to exhibit influence on gender
specific sleep habits [34]. Last but not least, lower socio-
economic status for women might partially explain the
discrepancy [19]. In the present study, after adjusting for
several well established risk factors for dyslipidemia, the
association of insomnia and dyslipidemia was still sig-
nificant in women. This indicated that other biological
mechanisms might play a role in the gender differences.
This research question should be addressed in future
large longitudinal cohort studies.
In the present study, we also analyzed the association
between insomnia and the individual components of
serum lipid. We found that insomnia was associated
with TC in women other than men, and we did not find
a significant association between insomnia and TG,
LDL-C, or HDL-C. This implied that the association
between insomnia and dyslipidemia might be mainly
due to the association of insomnia and TC. However,
studies which directly explore the association of insom-
nia and serum lipid are scarce. Most of them focused
on sleep duration and metabolic markers including
serum lipid.
Several potential mechanisms might be proposed to ex-
plain the link of insomnia and dyslipidemia. Firstly, insom-
nia usually contributed to reduced sleep duration. People
with reduced sleep duration tended to show a preference
of high energy-density fatty food [35] and have a higher
BMI via reducing leptin and elevating ghrelin [36,37].
Higher BMI and intake of fat rich food were able to in-
crease the risk of dyslipidemia [38]. In our study, the asso-
ciation of insomnia and dyslipidemia were still significant
after adjusting BMI and obesity. This indicates that the
observed association was independent of BMI or obesity.
The link should be further explained by other possible
mechanisms. Secondly, although the causes and physi-
ology of insomnia have not been completely understood, it
is generally considered as one kind of hyperarousal dis-
order related to increased activity of hypothalamic-
pituitary-adrenal-axis [13]. During this process, cortisol
[39] will be secreted excessively. Elevated cortisol is able
to induce higher cholesterol [40]. Finally, Insomnia and
dyslipidemia share some common risk factors, such as
smoking [41,42] and alcohol consumption [43]. Thus,
the abnormalities of the neuroendocrine system andunhealthy lifestyle may present a biological plausibility be-
tween insomnia and abnormal lipid status. In addition
to the aforementioned statements, depression or other
psychiatric disorder might act as mediators in the asso-
ciation between insomnia and dyslipidemia. A meta-
analysis using longitudinal epidemiological studies found
that non-depressed individuals with insomnia had a two-
fold risk to develop depression compared with those
without sleep difficulties [44]. Insomnia was also closely
relatred to other psychiatric disorder [45]. Patients with
major depressive or psychiatric disorders had a worse
lipid profile in the Netherlands Study of Depression and
Anxiety [46] as well as in a Chinese cohort [47]. In the
present study, depression and psychiatric disorders were
not measured, and further analysis regarding the mediat-
ing effects was unavailable. However, the mediation ef-
fects of depression and psychiatric disorders deserve
detailed examination in future studies.
Our results have meaningful implications for both
public health and clinical practice professionals. Since
insomnia is a modifiable risk factor for chronic diseases
including abnormal serum lipid profile, treating insom-
nia might have protective effects on lowering TC levels
as well as deceasing dyslipidemia prevalence. However,
more longitudinal studies and clinical trials are war-
ranted to examine the causal relationship between in-
somnia and dyslipidemia or whether treating insomnia
with medicine has beneficial effects on patients’ lipid
levels.
This study has some limitations. The present data was
collected using a cross-sectional design, we cannot make
causal inferences regarding whether insomnia precedes
or causes dyslipidemia. Furthermore, more women than
men participated in the survey. Women paid much more
attention to their health, which could result in an over-
estimation of the prevalence of insomnia in the source
population. But this would have little effect on the re-
ported association of insomnia and dyslipidemia after
stratifying analysis by gender. Finally, insomnia was col-
lected in a single question rather than multiple questions
proposed by other studies [13], so we cannot examine
the association between other insomnia symptoms and
dyslipidemia in the present study.
Conclusions
In conclusion, self-reported insomnia was associated
with higher prevalence of dyslipidemia and TC in this
large Chinese women sample. Future longitudinal stud-
ies should be conducted to further explore the causal
relationship and to clarify the biological mechanisms
between them.
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